2023 Study: Cannabis for Anxiety Disorders & PTSD
Updated: 5 days ago
This free Higher Learning LV training article is brought to you by the new Cannabis for Anxiety seminar. At only $80, this science-based training cites the latest peer-reviewed research to bring students the most current discoveries and insight into the potential commercial and medicinal applications of cannabis.
Cannabis for Anxiety Disorders & PTSD Study
A 2023 peer-reviewed research study entitled "Cannabis Update: Anxiety Disorders and Post-traumatic Stress Disorder" that was published in the Journal of the American Association of Nurse Practitioners examined the issue of the efficacy of cannabis for anxiety disorders, with a focus on Post-traumatic Stress Disorder (PTSD).
Cannabis for Anxiety Disorders & PTSD Study Conclusions
This abstract from this recent study is presented below:
Cannabis for Anxiety Disorders & PTSD. "The development of anxiety disorders and post-traumatic stress disorder (PTSD) is complex. Both delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are of potential therapeutic use. Evidence suggests that cannabis has a beneficial effect on neural circuitry involved in fear regulation.
"In the United States, cannabis is considered either medical or recreational and can contain pure THC or CBD or any combination thereof. The numerous cannabis compounds of various administration routes, with variable pharmacokinetics, further affect the cannabis conundrum.
"Federally unregulated, medical cannabis has received increased attention socially and, at present, 37 states, four territories, and Washington, D.C. have legalized medical cannabis for use in specific health conditions."
"Despite being federally unregulated, medical cannabis has received increased attention socially, and at present, 37 states, four territories, and the District of Columbia have legalized medical cannabis for use in specific health conditions.
Patients Increasingly Inquiring About Cannabis
"Patients are increasingly inquiring about cannabis, and clinicians must educate themselves with reliable cannabinoid information for patient education. In adults with anxiety disorders and PTSD, evidence supports a relatively safe profile for medical cannabis; however, conclusive scientific evidential support of its therapeutic properties is limited, resulting in a lack of standardization and Food and Drug Administration approval."
View the original study.
Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.